Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 16, 2026.
|Slideshows|April 24, 2017
Parkinson Disease: Genetic Findings
Author(s)Samantha J. Peterson
Research at AAN 2017 highlights research of genes that may help predict the likelihood of developing Parkinson disease and progression of the disease.
Advertisement
Studies from AAN 2017 presented research examining lysosomal storage disorder (LSD) genes associated with risk of Parkinson disease, questioning whether specific mutations of GBA gene impact progression of the disease, and tackling the challenge of utilizing whole-exome sequencing to identify genes linked to Parkinson disease risk in a large cohort of unrelated subjects.From materials presented at AAN Annual Meeting, Boston, MA. Best of: Parkinson Disease session. April 23, 2017.
Advertisement
Related to this article
A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.
The Galassia trial will evaluate the safety and tolerability of intranasal cenegermin in about 60 children with spastic cerebral palsy across Italy.
The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.
Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.
Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and nonmotor symptoms in Parkinson disease.
New cerebrospinal fluid biomarker data suggest shared LRRK2 pathway activation across sporadic and LRRK2-associated Parkinson disease, potentially informing biomarker development and therapeutic targeting.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Clene Submits NDA Seeking Accelerated Approval for ALS Drug
2
Decade of OPERA Data Supports Early Ocrelizumab Treatment Initiation in Relapsing Multiple Sclerosis
3
First-in-Human Trial Begins for an Antisense Oligonucleotide in KCNT1-Related Epilepsy
4
RGX-202 Meets Primary End Point in Phase 3 Duchenne Trial
5